The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT07042789




Registration number
NCT07042789
Ethics application status
Date submitted
4/06/2025
Date registered
29/06/2025
Date last updated
29/06/2025

Titles & IDs
Public title
Perception of Health Promotion Messages
Scientific title
Perception of Health Promotion Messages
Secondary ID [1] 0 0
2024/HE000725
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Perception of Vaping 0 0
Condition category
Condition code

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Other interventions - Material source: AI generated ads vs existing ads by health agency
Other interventions - source labelling conditions: control condition, AI condition, health agency condition, combined condition

Experimental: Control - Ads presented without any source labelling

Experimental: AI condition - Ads labelled with the text "Made with AI"

Experimental: Health authority condition - Ads labelled with the text "Made by the World Health Organization (WHO)"

Experimental: Combined condition - Ads labelled with the text "Made with AI, by the World Health Organization (WHO)"


Other interventions: Material source: AI generated ads vs existing ads by health agency
Each participant evaluated 50 ads in random order, of which 25 were AI-generated through youth co-design process, and 25 were existing ads from official health agencies.

Other interventions: source labelling conditions: control condition, AI condition, health agency condition, combined condition
Participants were randomly assigned to one of four source labelling conditions: (1) Control (ads presented without any source labelling), (2) AI condition (ads labelled with the text "Made with AI"), (3) Health agency condition (ads labelled with the text "Made by the World Health Organization (WHO)"), and (4) Combined condition (ads labelled with the text "Made with AI, by the World Health Organization (WHO)").

Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Perceived Message Effectiveness (PME)
Timepoint [1] 0 0
Within 30mins of exposure
Secondary outcome [1] 0 0
Vaping and Smoking Behaviour
Timepoint [1] 0 0
Within 30mins of exposure
Secondary outcome [2] 0 0
Vaping susceptibility
Timepoint [2] 0 0
Within 30mins of exposure
Secondary outcome [3] 0 0
Intention to quit
Timepoint [3] 0 0
Within 30mins of exposure
Secondary outcome [4] 0 0
Health behaviour
Timepoint [4] 0 0
Within 30mins of exposure
Secondary outcome [5] 0 0
Trust in health agencies
Timepoint [5] 0 0
Within 30mins of exposure
Secondary outcome [6] 0 0
Demographics
Timepoint [6] 0 0
Within 30mins of exposure
Secondary outcome [7] 0 0
General attitudes towards artificial intelligence scale (GAAIS)
Timepoint [7] 0 0
Within 30mins of exposure

Eligibility
Key inclusion criteria
* Living in Australia
* Aged 16-25 years
* Able to read English
* Committed to reviewing each advertisement and providing honest, personal responses
Minimum age
16 Years
Maximum age
25 Years
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
* Unwilling to commit to reviewing each advertisement honestly
* Unable to promise to provide genuine responses to survey questions

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


The people analysing the results/data
Intervention assignment
Factorial
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 0 0
National Centre for Youth Substance Use Research - Brisbane
Recruitment postcode(s) [1] 0 0
4068 - Brisbane

Funding & Sponsors
Primary sponsor type
Other
Name
The University of Queensland
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

No documents have been uploaded by study researchers.